Moritz Pohl

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Assessing the hierarchical beta-binomial model as a basic information sharing tool in basket trials.

Assessing the hierarchical beta-binomial model as a basic information sharing tool in basket trials.

Journal: Journal of biopharmaceutical statistics

Published: September 27, 2024

Model of integrated mental health video consultations for people with depression or anxiety in primary care (PROVIDE-C): assessor masked, multicentre, randomised controlled trial.

Model of integrated mental health video consultations for people with depression or anxiety in primary care (PROVIDE-C): assessor masked, multicentre, randomised controlled trial.

Journal: BMJ (Clinical research ed.)

Published: September 25, 2024

Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.

Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.

Journal: EBioMedicine

Published: September 17, 2024

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease.

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease.

Journal: Respiratory research

Published: August 23, 2024

Phenotyping of COPD with MRI in comparison to same-day CT in a multi-centre trial.

Phenotyping of COPD with MRI in comparison to same-day CT in a multi-centre trial.

Journal: European radiology

Published: September 10, 2023

Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy.

Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy.

Journal: Clinical and translational science

Published: July 04, 2023

Influence of Lung Reconstruction Algorithms on Interstitial Lung Pattern Recognition on CT.

Influence of Lung Reconstruction Algorithms on Interstitial Lung Pattern Recognition on CT.

Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Published: September 06, 2022

Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.

Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.

Journal: European radiology

Published: August 12, 2022

"Will I change nodule management recommendations if I change my CAD system?"-impact of volumetric deviation between different CAD systems on lesion management.

"Will I change nodule management recommendations if I change my CAD system?"-impact of volumetric deviation between different CAD systems on lesion management.

Journal: European radiology

Published: July 12, 2022

Up to 10 years clinical performance of zirconia ceramic and metal-ceramic fixed partial dentures: A retrospective study.

Up to 10 years clinical performance of zirconia ceramic and metal-ceramic fixed partial dentures: A retrospective study.

Journal: The Journal of prosthetic dentistry

Published: February 16, 2022

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).

Journal: Radiation oncology (London, England)

Published: January 31, 2022

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations.

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations.

Journal: Frontiers in oncology

Published: August 11, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026